These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34984207)

  • 41. Totally implantable venous access devices via subclavian vein: a retrospective study of 368 oncology patients.
    Ozyuvaci E; Kutlu F
    Adv Ther; 2006; 23(4):574-81. PubMed ID: 17050500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
    Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F
    Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study.
    Tumay LV; Guner OS
    Support Care Cancer; 2021 Jul; 29(7):3531-3538. PubMed ID: 33155092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Infection assessment of totally implanted long-term venous access devices.
    Brouns F; Schuermans A; Verhaegen J; De Wever I; Stas M
    J Vasc Access; 2006; 7(1):24-8. PubMed ID: 16596525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoport-skin erosion: our experience.
    Harish K
    Int J Angiol; 2014 Sep; 23(3):215-6. PubMed ID: 25317035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. External Jugular Venous Cutdown versus Percutaneous Technique for Chemoport Insertion in Children: A Comparative Study.
    Radhakrishna V; Radhakrishnan CN; Srinivasa Rao RC; Kireeti G
    J Indian Assoc Pediatr Surg; 2022; 27(2):140-146. PubMed ID: 35937132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Totally implantable ports connected to valved catheters for chemotherapy: experience from 350 Groshong devices.
    Nishinari K; Wolosker N; Bernardi CV; Yazbek G
    J Vasc Access; 2010; 11(1):17-22. PubMed ID: 20119917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Totally implantable femoral vein catheters in cancer patients.
    Wolosker N; Yazbek G; Munia MA; Zerati AE; Langer M; Nishinari K
    Eur J Surg Oncol; 2004 Sep; 30(7):771-5. PubMed ID: 15296992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical application of totally implantable central venous port].
    Sun Y; Zhou T; Li Y; Wang J; Jiao J; Wang H; Geng C
    Zhonghua Wai Ke Za Zhi; 2014 Aug; 52(8):608-11. PubMed ID: 25370762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
    Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
    Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Totally implantable venous catheters for chemotherapy: experience in 500 patients.
    Wolosker N; Yazbek G; Nishinari K; Malavolta LC; Munia MA; Langer M; Zerati AE
    Sao Paulo Med J; 2004 Jul; 122(4):147-51. PubMed ID: 15543368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Totally implantable central venous catheters of the port-a-cath type: complications due to its use in the treatment of cancer patients.
    Granic M; Zdravkovic D; Krstajic S; Kostic S; Simic A; Sarac M; Ivanovic N; Radovanovic D; Dikic S; Kovcin V
    J BUON; 2014; 19(3):842-6. PubMed ID: 25261677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of an implantable venous access system in a general oncology population.
    Barrios CH; Zuke JE; Blaes B; Hirsch JD; Lyss AP
    Oncology; 1992; 49(6):474-8. PubMed ID: 1465287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases].
    Schenck M; Michels-Oswald W; Tschirdewahn S; Rübben H; Vom Dorp F; Rose A; Panic A; Niedworok C; Rossi R
    Urologe A; 2012 Feb; 51(2):226-37. PubMed ID: 21927874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Totally implantable central venous port: analysis of complications and their prevention].
    Smolyar AN; Ginzburg LM; Smirnov MA
    Khirurgiia (Mosk); 2019; (12):13-17. PubMed ID: 31825338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of totally implantable central venous access port via the basilic vein in patients with thoracic malignancies.
    Sonobe M; Chen F; Fujinaga T; Sato K; Shoji T; Sakai H; Miyahara R; Bando T; Okubo K; Hirata T; Date H
    Int J Clin Oncol; 2009 Jun; 14(3):208-12. PubMed ID: 19593611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
    Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
    Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.